Natural killer cells and single nucleotide polymorphisms of specific ion channels and receptor genes in myalgic encephalomyelitis/chronic fatigue syndrome

被引:41
|
作者
Marshall-Gradisnik, Sonya [1 ,2 ]
Huth, Teilah [1 ,2 ]
Chacko, Anu [1 ,2 ]
Johnston, Samantha [1 ,2 ]
Smith, Pete [2 ]
Staines, Donald [2 ]
机构
[1] Griffith Univ, Menzies Hlth Inst Queensland, Sch Med Sci, Gold Coast, Qld, Australia
[2] Griffith Univ, Menzies Hlth Inst Queensland, Natl Ctr Neuroimmunol & Emerging Dis, Parklands Dr, Gold Coast, Qld 4222, Australia
来源
关键词
chronic fatigue syndrome; myalgic encephalomyelitis; transient receptor potential ion channels; acetylcholine receptors; genotypes;
D O I
10.2147/TACG.S99405
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Aim: The aim of this paper was to determine natural killer (NK) cytotoxic activity and if single nucleotide polymorphisms (SNPs) and genotypes in transient receptor potential (TRP) ion channels and acetylcholine receptors (AChRs) were present in isolated NK cells from previously identified myalgic encephalomyelitis (ME)/chronic fatigue syndrome (CFS) patients. Subjects and methods: A total of 39 ME/CFS patients (51.69 +/- 2 years old) and 30 unfatigued controls (47.60 +/- 2.39 years old) were included in this study. Patients were defined according to the 1994 Centers for Disease Control and Prevention criteria. Flow cytometry protocols were used to examine NK cytotoxic activity. A total of 678 SNPs from isolated NK cells were examined for 21 mammalian TRP ion channel genes and for nine mammalian AChR genes via the Agena Bioscience iPlex Gold assay. SNP association and genotype was determined using analysis of variance and Plink software. Results: ME/CFS patients had a significant reduction in NK percentage lysis of target cells (17%+/- 4.68%) compared with the unfatigued control group (31%+/- 6.78%). Of the 678 SNPs examined, eleven SNPs for TRP ion channel genes (TRPC4, TRPC2, TRPM3, and TRPM8) were identified in the ME/CFS group. Five of these SNPs were associated with TRPM3, while the remainder were associated with TRPM8, TRPC2, and TRPC4 (P<0.05). Fourteen SNPs were associated with nicotinic and muscarinic AChR genes: six with CHRNA3, while the remainder were associated with CHRNA2, CHRNB4, CHRNA5, and CHRNE (P<0.05). There were sixteen genotypes identified from SNPs in TRP ion channels and AChRs for TRPM3 (n=5), TRPM8 (n=2), TRPC4 (n=3), TRPC2 (n=1), CHRNE (n=1), CHRNA2 (n=2), CHRNA3 (n=1), and CHRNB4 (n=1) (P<0.05). Conclusion: We identified a number of SNPs and genotypes for TRP ion channels and AChRs from isolated NK cells in patients with ME/CFS, suggesting these SNPs and genotypes may be involved in changes in NK cell function and the development of ME/CFS pathology. These anomalies suggest a role for dysregulation of Ca2+ in AChR and TRP ion channel signaling in the pathomechanism of ME/CFS.
引用
收藏
页码:39 / 47
页数:9
相关论文
共 50 条
  • [42] Altered fatty acid oxidation in T and NK cells in myalgic encephalomyelitis/chronic fatigue syndrome
    Maya, Jessica
    Hanson, Maureen R.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2021, 51 : 325 - 325
  • [43] Herpesvirus Infection of Endothelial Cells as a Systemic Pathological Axis in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
    Nunes, Jean M.
    Kell, Douglas B.
    Pretorius, Etheresia
    VIRUSES-BASEL, 2024, 16 (04):
  • [44] Induced pluripotent stem cells as suitable sensors for fibromyalgia and myalgic encephalomyelitis/chronic fatigue syndrome
    Monzon-Nomdedeu, Maria B.
    Morten, Karl J.
    Oltra, Elisa
    WORLD JOURNAL OF STEM CELLS, 2021, 13 (08): : 1134 - 1150
  • [45] Potential Therapeutic Benefit of Low Dose Naltrexone in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Role of Transient Receptor Potential Melastatin 3 Ion Channels in Pathophysiology and Treatment
    Cabanas, Helene
    Muraki, Katsuhiko
    Eaton-Fitch, Natalie
    Staines, Donald Ross
    Marshall-Gradisnik, Sonya
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [46] How Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Progresses: The Natural History of ME/CFS
    Nacul, Luis
    O'Boyle, Shennae
    Palla, Luigi
    Nacul, Flavio E.
    Mudie, Kathleen
    Kingdon, Caroline C.
    Cliff, Jacqueline M.
    Clark, Taane G.
    Dockrell, Hazel M.
    Lacerda, Eliana M.
    FRONTIERS IN NEUROLOGY, 2020, 11
  • [47] Natural killer cells in patients with severe chronic fatigue syndrome
    Brenu, E. W.
    Hardcastle, S. L.
    Atkinson, G. M.
    van Driel, M. L.
    Kreijkamp-Kaspers, S.
    Ashton, K. J.
    Staines, D. R.
    Marshall-Gradisnik, S. M.
    AUTOIMMUNITY HIGHLIGHTS, 2013, 4 (03) : 69 - 80
  • [48] Experiences of pain in paediatric chronic fatigue syndrome/myalgic encephalomyelitis: a single-centre qualitative study
    Serafimova, Teona
    Ascough, Caitlin
    Parslow, Roxanne Morin
    Crawley, Esther
    BMJ PAEDIATRICS OPEN, 2022, 6 (01)
  • [49] Single Cell Immune Atlas of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Identifies Substantial Transcriptional Dysregulation
    Iu, David S.
    Grimson, Andrew
    JOURNAL OF IMMUNOLOGY, 2023, 210 (01):
  • [50] Changes in the transcriptome of circulating immune cells of a New Zealand cohort with myalgic encephalomyelitis/chronic fatigue syndrome
    Sweetman, Eiren
    Ryan, Margaret
    Edgar, Christina
    MacKay, Angus
    Vallings, Rosamund
    Tate, Warren
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2019, 33